Hangzhou Just Biotherapeutics
Room 805, Xinmao Building
Taicang Road
Hangzhou
Zhejiang
China
Tel: 0571-28279502
Website: http://www.justbiochina.com/
Email: media@justbiochina.com
About Hangzhou Just Biotherapeutics
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company dedicated to accelerating the development of bio-medicine and significantly reducing manufacturing costs. Our core strengths are molecular design, process design, drug product design and manufacturing plant design.YEAR FOUNDED:
2014
LEADERSHIP:
Founders: James N. Thomas, Victor P. Fung, Dean K. Pettit, Zhao Yining
4 articles about Hangzhou Just Biotherapeutics
-
China’s Hillhouse Capital Group, an equity investment firm, has a new fund, Hillhouse Fund IV, with $10.6 billion ready to invest.
-
Hangzhou Just Biotherapeutics Secures $35 Million Series B+ Financing
6/6/2018
To enhance R&D capabilities and accelerate clinical trials globally
-
Hangzhou Just Biotherapeutics Opens R&D Center and GMP Manufacturing Facility to Develop Biologic Medicines Globally
1/22/2018
Around 200 guests including business partners, investors and representatives from pharmaceutical companies were present to witness this historical moment.
-
Hangzhou Just Biotherapeutics Scores $57M to Further Advance Biologics Development and Clinical Trials
8/9/2017